---
category: news
title: "BioXcel Therapeutics Announces Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology"
excerpt: "OnkosXcel, a Company subsidiary, to utilize proprietary AI-powered platform to progress therapies to address difficult-to-treat cancers with high unmet need New structure to unlock growth opportunities and maximize value of neuroscience and immuno-oncology franchises Lead pipeline asset,"
publishedDateTime: 2022-04-19T12:05:00Z
originalUrl: "https://www.texomashomepage.com/business/press-releases/globenewswire/8524357/bioxcel-therapeutics-announces-formation-of-onkosxcel-therapeutics-to-develop-medicines-focused-in-oncology/"
webUrl: "https://www.texomashomepage.com/business/press-releases/globenewswire/8524357/bioxcel-therapeutics-announces-formation-of-onkosxcel-therapeutics-to-develop-medicines-focused-in-oncology/"
type: article

provider:
  name: TexomasHomepage.com
  domain: texomashomepage.com

topics:
  - AI in Healthcare
  - AI

secured: "8e37V0ruHgacnuaCItvkQlRP0oXGAyEonW3hggN0J8gIk1cG4X5Z5ephiyyFHzXQY12RQ940bT1+BpGMaOQzEcol/YEyNzTqqtbt5iQmdQo7zwIljOCtS80H9K+j5vSzWjTzozEKb+k3ofxy6P1twuK3MWR40IMQXPQSenqOz+/NWbO/0b/jEdBCp7K9Y5jIA4NgqpjJd+SDnCo0jKs6i9ePcPOSGthm/ATvfLikEjj31T0Me87Vyt7iPXQJ/96ObNieLP36aSh+B0XmGaHRF8X2KHeE5yrOmaDvHaSKdoKW5cggnSUezr59t+bTEM+9WBxW2gSxp2dNbZB/Z2B2ZBKEAg7vkDbKOz40fLQOjoI=;hVI6M1wJyGtM73GABJ9Nww=="
---

